Vanderbilt-Ingram Cancer Center Archive — Page 10 of 28
-
January 4, 2024
Potential AML therapy induces leukemic stem cell death
Vanderbilt researchers are studying a potential therapy for acute myeloid leukemia that targets the residual leukemic stem cells in bone marrow after treatment that are responsible for relapses and drug resistance. -
December 20, 2023
Appointments, additions in 2023 strengthen VUMC’s core missions
During the past year, multiple new appointments and additions strengthened VUMC’s core missions. -
December 15, 2023
Clinical trial shows efficacy for atezolizumab combined with carboplatin
-
December 14, 2023
Sam S. Chang recognized by the American Urological Association
The American Urological Association has announced that Vanderbilt's Sam S. Chang, MD, MBA, is one of its 2024 award recipients. -
November 30, 2023
Ukrainian oncologists visit Vanderbilt-Ingram Cancer Center
A group of Ukrainian oncologists recently visited Vanderbilt-Ingram Cancer Center where they toured research labs, observed tumor board meetings, met with several Vanderbilt oncologists, and attended the 23rd Annual Retreat for Cancer Biology. -
November 17, 2023
Keith Obstein receives inaugural Brock Family Center Innovator of the Year Award
Keith Obstein, MD, MPH, has received the inaugural Innovator of the Year Award from the Brock Family Center for Applied Innovation in recognition of his achievements in developing and commercializing a magnetic, flexible colonoscopy system with the potential to provide a safer alternative to standard colonoscopy. -
November 17, 2023
Vanderbilt’s Dr. W. Kimryn Rathmell to be appointed director of the National Cancer Institute
Kimryn Rathmell, MD, PhD, MMHC, the Hugh Jackson Professor of Medicine and chair of the Department of Medicine at Vanderbilt University Medical Center (VUMC), has been named director of the National Cancer Institute